Rare Diseases: Shaping Biopharma’s Future from the Past
We just completed Rare Disease month. With that in mind, Sue has asked me to…
“Rare Disease” Is More Than Just a Day
You might think it odd for me to begin this month’s e-conversation with a quote…
Patient Advocacy – Delivering on Patient Centricity in Drug Development
Historically, biopharma companies developed drugs for patients with an illness…
Reactive Leadership in Biopharma: Breaking the Whac-A-Mole Cycle
Today we examine a pervasive challenge in our industry: time and resources wasted as middle and senior leaders respond to a seemingly endless, daily…
Your Future Story … How Good Is It?
Summer, sadly, is over. And while there are noticeable shifts with each change of season, I find the transition into autumn can often be bittersweet.